State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences

Cancer

Volumn 121, Issue 20, 2015, Pages 3676-3683

  Lansdorp Vogelaar, Iris ^a   Goede, S Lucas ^a   Ma, Jiemin ^b   Xiau Cheng, Wu ^c   Pawlish, Karen ^d   Van Ballegooijen, Marjolein ^a   Jemal, Ahmedin ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMERICAN CANCER SOCIETY   (United States)

^c LSUHSC School of Public Health   (United States)

^d NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

colorectal cancer; computer simulation; prevention and control; screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MICROSIMULATION SCREENING ANALYSIS COLON MICROSIMULATION MODEL; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SURVIVAL RATE; UNITED STATES; VALIDITY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; LOUISIANA; MIDDLE AGED; MORTALITY; NEW JERSEY; STATISTICAL MODEL; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEALTHCARE DISPARITIES; HUMANS; LOUISIANA; MIDDLE AGED; MODELS, STATISTICAL; MORTALITY; NEW JERSEY; RISK ASSESSMENT; RISK FACTORS;

EID: 84943583864     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29561     Document Type: Article

References (29)

1. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
2. Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A,. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1296-1302.
3. DeLancey JO, Thun MJ, Jemal A, Ward EM,. Recent trends in black-white disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2908-2912.
4. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD,. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res. 1999; 32: 13-33.
5. Koretz RL,. Malignant polyps: are they sheep in wolves' clothing? Ann Intern Med. 1993; 118: 63-68.
6. National Cancer Institute. SEER∗Stat software, version 5.3.1. http://seer.cancer.gov/seerstat/software/. Accessed September 25, 2014.
7. Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JD,. A novel hypothesis on the sensitivity of the fecal occult blood test: results of a joint analysis of 3 randomized controlled trials. Cancer. 2009; 115: 2410-2419.
8. Stoop EM, de Haan MC, de Wijkerslooth TR, et al., Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012; 13: 55-64.
9. Louisiana State University School of Public Health. Louisiana Tumor Registry. http://sph.lsuhsc.edu/louisiana-tumor-registry. Accessed September 25, 2014.
10. Baili P, Micheli A, De Angelis R, et al., Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori. 2008; 94: 658-668.
11. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. http://www.cdc.gov/brfss/. Accessed September 25, 2014.
12. Giovannucci E, Rimm EB, Stampfer MJ, et al., A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst. 1994; 86: 183-191.
13. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC,. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995; 122: 327-334.
14. Atkin WS, Edwards R, Kralj-Hans I, et al., Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375: 1624-1633.
15. Loeve F, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JDF,. Final Report MISCAN-COLON Microsimulation Model for Colorectal Cancer: Report to the National Cancer Institute Project No. NO1-CN55186. Rotterdam, the Netherlands: Erasmus University; 1998.
16. Loeve F, Boer R, Zauber AG, et al., National Polyp Study data: evidence for regression of adenomas. Int J Cancer. 2004; 111: 633-639.
17. Edwards BK, Ward E, Kohler BA, et al., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
18. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
19. Levin B, Lieberman DA, McFarland B, et al., Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
20. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L,. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008; 103: 1541-1549.
21. Harper S, Lynch J,. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. Bethesda, MD: National Cancer Institute; 2005. NCI Cancer Surveillance Monograph Series; vol 6. NIH publication 05-5777.
22. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS,. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997; 112: 17-23.
23. American Board of Internal Medicine. Candidates certified by US state/territory. https://www.abim.org/pdf/data-candidates-certified/State-Number-of-Certificates-Issued.pdf. Accessed September 25, 2014.
24. Moayyedi P, Tepper J, Hilsden R, Rabeneck L,. International comparisons of manpower in gastroenterology. Am J Gastroenterol. 2007; 102: 478-481.
25. Cress RD, Sabatino SA, Wu XC, et al., Adjuvant chemotherapy for patients with stage III colon cancer: results from a CDC-NPCR patterns of care study. Clin Med Oncol. 2009; 3: 107-119.
26. Hassan MO, Arthurs Z, Sohn VY, Steele SR,. Race does not impact colorectal cancer treatment or outcomes with equal access. Am J Surg. 2009; 197: 485-490.
27. Hofmann LJ, Lee S, Waddell B, Davis KG,. Effect of race on colon cancer treatment and outcomes in the Department of Defense healthcare system. Dis Colon Rectum. 2010; 53: 9-15.
28. Sanoff HK, Sargent DJ, Green EM, McLeod HL, Goldberg RM,. Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol. 2009; 27: 4109-4115.
29. Grubbs SS, Polite BN, Carney J Jr, et al., Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013; 31: 1928-1930.